USPTO trademark

ICREBDA

RegisteredUSPTOWord markClass 5

"ICREBDA" is a word mark owned by Glaxo Group Limited, filed at the USPTO on March 25, 2025. It is registered and covers class 5 (Pharmaceuticals).

View Glaxo Group Limited portfolioGet this data via the API
Official USPTO record
ICREBDA trademark as filed
As filed with the USPTO
Status
Registered
Since October 28, 2025
Filed
March 25, 2025
Registered
October 28, 2025
Expires
Not recorded
Application no.
99102009
Registration no.
8004892
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns ICREBDA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Glaxo Group Limited

Stevenage, United Kingdom

19,383 trademarks in the portfolioView company

Representative

Elizabeth K. Rucki

GSK

Goods and services

What the mark covers

The products and services ICREBDA is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Official gazette publication confirmation e-mailed
  4. Published for opposition
  5. Notification of notice of publication e-mailed
  6. Approved for pub - principal register
  7. Assigned to examiner
  8. Application filing receipt mailed
  9. New application office supplied data entered
  10. New application entered
FAQ

About ICREBDA

Who owns the trademark "ICREBDA"?

The USPTO trademark "ICREBDA" (application 99102009) is owned by Glaxo Group Limited.

What is the status of "ICREBDA"?

Its status at the USPTO is: registered.

When was "ICREBDA" registered?

It was registered on October 28, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ICREBDA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2a98-1fd1-71dd-ad35-b15717cccaea
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2a98-1fd1-71dd-ad35-b15717cccaea",
  "object": "trademark",
  "mark_text": "ICREBDA",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "99102009",
  "filing_date": "2025-03-25",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Glaxo Group Limited",
      "entity_id": "ent_019eb6f6-4cb9-77ae-916f-63b3231a6d3d"
    }
  ]
}